Proton relaxation enhancement in experimental brain tumors--in vivo NMR study of manganese(III)TPPS in rat brain gliomas.

The effect of manganese(III)tetraphenylporphine sulfonate (MnTPPS) on the relaxation enhancement of NMR images (MRI) was studied in experimental brain tumors in rats. Brains were inoculated with the glioma cell line F98 12 to 19 days before the NMR experiment, and the effect of MnTPPS (0.25 mmol/kg body weight) was investigated 2 and 4 days after intraperitoneal injection. After MnTPPS addition tumors could be clearly distinguished by the brightness from the surrounding brain whereas they were barely visible without contrast enhancement. At SE time of 25 msec and TR time of 3500 msec the ratio of magnetization values of tumor versus normal grey matter increased from 0.98 +/- 0.08 to 1.24 +/- 0.09 (means +/- SD). When TR was shortened to 1100 msec contrast enhancement further increased to 1.77 +/- 0.25. These results demonstrate for the first time that MnTPPS is an efficient agent for contrast enhancement of brain tumors.

[1]  J. Winkelman,et al.  The distribution of tetraphenylporphinesulfonate in the tumor-bearing rat. , 1962, Cancer research.

[2]  C. Dickman,et al.  Unenhanced and gadolinium-DTPA-enhanced MR imaging in postoperative evaluation in pediatric brain tumors. , 1989, Journal of neurosurgery.

[3]  S. Snyder,et al.  Characterization of porphyrin interactions with peripheral type benzodiazepine receptors. , 1988, Molecular pharmacology.

[4]  S. H. Koenig,et al.  Tissue distribution and stability of metalloporphyrin MRI contrast agents , 1987, Magnetic resonance in medicine.

[5]  P. Lelkes,et al.  Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells. , 1987, Biochimica et biophysica acta.

[6]  S H Snyder,et al.  The peripheral‐type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  M. Bronskill,et al.  Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system. , 1987, Magnetic resonance imaging.

[8]  P. Skolnick,et al.  CHARACTERIZATION OF BENZODIAZEPINE BINDING SITES IN CULTURED CELLS OF NEURAL ORIGIN , 1979, Journal of neurochemistry.

[9]  S. H. Koenig,et al.  The anomalous relaxivity of Mn3+(TPPS4) , 1987, Magnetic resonance in medicine.

[10]  J. S. Cohen,et al.  Paramagnetic metalloporphyrins as potential contrast agents in NMR imaging , 1984, FEBS letters.

[11]  A. Dwyer,et al.  Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice. , 1986, Cancer treatment reports.

[12]  T. Button,et al.  Mechanism of the localization of manganese (III) mesotetra(4-sulfonatophenyl)porphine in mice bearing L1210 tumors. , 1988, Cancer letters.

[13]  D. Kessel,et al.  HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY , 1984, Photochemistry and photobiology.

[14]  Imaging of brain tumors using peripheral benzodiazepine receptor ligands. , 1989, Journal of neurosurgery.

[15]  S H Snyder,et al.  Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.